Which prescription medications are covered by the Janssen Ortho Patient Assistance Foundation Hospital Access Patient Assistance Program?
The following prescription medications are included in this program: INVEGA™ (paliperidone) Extended-Release Tablets RISPERDAL® (risperidone) Tablets/Oral Solution LEVAQUIN® (levofloxacin) Tablets/Oral Solution ULTRACET® (tramadol hydrochloride/acetaminophen) Tablets TOPAMAX® (topiramate) Sprinkle Capsules and Tablets DITROPAN XL® (oxybutynin chloride) Extended-Release Tablets What are the program parameters? The program is intended to provide qualified patients access to medications through a qualified DSH or DRG-exempt Cancer Center. DSH facilities and DRG-exempt Cancer Centers are assessed for eligibility according to standardized criteria. Following approval, the DSH facility or DRG-exempt Cancer Center is required to sign a contract, follow standardized patient eligibility guidelines and agree to regular on-site audits.
Related Questions
- Which prescription medications are covered by the Janssen Ortho Patient Assistance Foundation Hospital Access Patient Assistance Program?
- Which hospitals are eligible for the Janssen Ortho Patient Assistance Foundation Hospital Access Patient Assistance Program?
- How do I learn more about the Janssen Ortho Patient Assistance Foundation Hospital Access Patient Assistance Program?